• Executive Summary of 2025 International Conference of the Korean Dementia Association and International Congress of the Asian Society Against Dementia (IC-KDA/ASAD 2025): A Report From the Academic Committee of the Korean Dementia Association
• Jaeho Kim ,1 Geon Ha Kim ,2 Kyunghun Kang ,3 Hee Jin Kim ,4 Jeewon Suh ,5 Bora Yoon ,6 Hanna Cho ,7 Jung-Min Pyun ,8 Young Ho Park ,8 Han Kyoung Choe ,9 Yun Kyung Kim ,10 Kun Ho Lee ,11 Jae Gwan Kim ,12 Soh-Jeong Yang ,13 Min Jae Baek ,8 Juhee Chin ,14 Hyemin Jang ,15 So Young Moon ,16 on behalf of Academic Committee of the Korean Dementia Association

Dementia and Neurocognitive Disorders 2025; 24: 209 - 232

• Home-Based Occupational Therapy Intervention for the Improvement of Quality of Life in Individuals With Moderate to Severe Dementia and Their Caregivers
• Home-Based Occupational Therapy Intervention for the Improvement of Quality of Life in Individuals With Moderate to Severe Dementia and Their Caregivers
• Theodosis Georgiadis ,1 Ioanna Giannoula Katsouri ,2 Charalampos Tsormpatzoudis ,3 Magdalini Tsolaki 4

Dementia and Neurocognitive Disorders 2025; 24: 233 - 245

• Mendelian Randomization Reveals Unidirectional Links Between Amyloid-β and Tau in Alzheimer’s Disease
• Mendelian Randomization Reveals Unidirectional Links Between Amyloid-β and Tau in Alzheimer’s Disease
• Jun Pyo Kim ,1,* Hyunwoo Lee ,2,3,* Bo-Hyun Kim ,2 Kwangsik Nho ,4 Shannon L Risacher ,4 Andrew J Saykin ,4 Sang Won Seo ,1,2 Han-Na Kim 5,6

Dementia and Neurocognitive Disorders 2025; 24: 246 - 258

• Gait Patterns and Balance Impairment in Parkinson’s Disease With Correlation to Disease Severity
• Gait Patterns and Balance Impairment in Parkinson’s Disease With Correlation to Disease Severity
• Danyeong Kim ,1,2 Da-Eun Jeong ,1 Hyunkyung Yi ,3 Min Ju Kang 1

Dementia and Neurocognitive Disorders 2025; 24: 259 - 271

• Mesenchymal Stem Cells With Adjuvant Dexamethasone in Patients With Alzheimer’s Disease: A Phase IIa Trial
• Mesenchymal Stem Cells With Adjuvant Dexamethasone in Patients With Alzheimer’s Disease: A Phase IIa Trial
• Na Kyung Lee ,1,2,* Hyemin Jang ,3,4,5,* Yejoo Choi,2 Song Hwangbo,4,5,6 Seunghoon Lee,7 Jung Il Lee ,7 Young Ju Kim,5 Juhee Chin ,5 Jong Wook Chang ,1,2 Sang Won Seo ,1,4,5,8,9 Hyo Jin Son ,2,4,5 Soo Jin Choi,10 Duk L. Na ,2,4,5,11 Hee Jin Kim 1,2,4,5,9

Dementia and Neurocognitive Disorders 2025; 24: 272 - 285

• Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment
• Clinical Utility and Diagnostic Accuracy of the Tablet-Based Seoul Cognitive Status Test: Evidence for Scalable Cognitive Assessment
• Young Ju Kim ,1,* Joon Soo Shin ,1,* Dayeong An ,1,2 Duk L. Na ,1,2 Hee Jin Kim 3,4,5,6

Dementia and Neurocognitive Disorders 2025; 24: 286 - 300

• Effects of a 12-Week Hybrid Analog–Digital Cognitive Training on Cognitively Unimpaired Older Adults: A Pilot Single-Blind Randomized Controlled Trial
• Effects of a 12-Week Hybrid Analog–Digital Cognitive Training on Cognitively Unimpaired Older Adults: A Pilot Single-Blind Randomized Controlled Trial
• Seungwon Chung ,1 Bori R. Kim ,2 Sooin Moon ,3 Geon Ha Kim 1

Dementia and Neurocognitive Disorders 2025; 24: 301 - 310

• Extensive Cerebral White Matter Involvement and Migrainous Headache in a Patient With Aquaporin-4-Positive NMOSD Mimicking CADASIL
• Extensive Cerebral White Matter Involvement and Migrainous Headache in a Patient With Aquaporin-4-Positive NMOSD Mimicking CADASIL
• Sukyoon Lee ,1 Seong-il Oh 2

Dementia and Neurocognitive Disorders 2025; 24: 311 - 314